iOS app Android app

Pharmaceutical Industry

Lifestyle as Medicine: At a Fork in the Road, Who's Got a Spoon?

David Katz, M.D. | Posted 01.25.2014 | Healthy Living
David Katz, M.D.

Lifestyle is the greatest of all medicine, but it may feel in this morbidigenic, obesigenic world of ours that we can't get it to go down, because we just don't have the right spoon. It may feel that we can't get there from here. That is, in a word, wrong.

Statin Drugs, Profits, Politics, and Compassion

Arthur Rosenfeld | Posted 01.25.2014 | Healthy Living
Arthur Rosenfeld

The latest guidelines for statin drugs, issued by the makers of those drugs, would have us believe that pretty much everyone should be taking them. Th...

Statins for Women? Not for My Patients

Kelly Brogan, M.D. | Posted 01.25.2014 | Healthy Living
Kelly Brogan, M.D.

All told, we have here an unsafe, unnecessary product that will now be recommended to healthy people to make them sicker, all when simple, health-fortifying lifestyle changes have been proven to be effective and globally transformative in ways no pill could ever hope to be.

Big Pharma Could Win International Price Monopoly, Unlimited Profits in 'Free Trade' Deal

Ethan Rome | Posted 01.25.2014 | Politics
Ethan Rome

Big Pharma has a new tool to make turbo-charged profits and insulate itself from efforts to rein in skyrocketing health costs.

The Statin Insanity

David H. Newman, M.D. | Posted 01.23.2014 | Healthy Living
David H. Newman, M.D.

We currently have a statin epidemic, with 25 percent of adults over the age of 45 taking the pills, a large majority of whom do not have heart disease and have not seen the numbers.

Bottle Tops and Breast Cancer: Pushing Mammograms With Every Prescription

Karuna Jaggar | Posted 01.23.2014 | Impact
Karuna Jaggar

Overly simplified messages about early detection too often ends up blaming women for their cancers or gives them false assurances that the treatment they are enduring is ultimately all for the best. Medical advice on a complex issue.

Novo Nordisk CEO on Obamacare: "Get on with it"

Daniel Moulthrop | Posted 12.17.2013 | Politics
Daniel Moulthrop

The CEO of one of the world's largest health industry companies spent a few days in Cleveland this week. He had a simple message for US lawmakers when...

Food Dyes: Red Does Not Mean GO

Christopher Gavigan | Posted 11.23.2013 | Healthy Living
Christopher Gavigan

Petroleum-derived colors are cheaper. Plain and simple. But they're not safe and they're completely unnecessary given modern sourcing and manufacturing. It's time to end this chapter of chemical history and say "the end" to these questionable hues.

Meeting Global Development Goals Requires More Cross-Sector Partnerships

Aron Cramer | Posted 11.19.2013 | Impact
Aron Cramer

With less than 800 days before the deadline for the UN Millennium Development Goals -- goals set by UN member states to accelerate development in the poorest countries -- it's time to take stock of the milestones achieved and think about what needs to change in order to meet the new goals we will set for post-2015.

Your Medication Can Kill You!

David Katz, M.D. | Posted 10.16.2013 | Healthy Living
David Katz, M.D.

Yes, side effects of medications can kill. But so can the side effects of declining medications we really need. When prescribed judiciously by clinicians who know what they are doing to patients who know what they are getting, drugs are far more likely to help than harm.

Ryan Grim

One Man Shows Just How Corrupt Washington Is

HuffingtonPost.com | Ryan Grim | Posted 08.13.2013 | Politics

WASHINGTON -- When Billy Tauzin stepped down as the high-profile head of the pharmaceutical lobby in 2010, The New York Times penned his political obi...

When Your Medicine Makes You Sick

Spencer Aronfeld | Posted 10.08.2013 | Healthy Living
Spencer Aronfeld

Once the FDA forces drug manufacturers to directly contact consumers who have been prescribed or are taking recalled medicine, it will send a strong message that patient safety is more important than corporate profit.

How One CEO Found Success in a Depressed Economy

Elizabeth Denham | Posted 10.05.2013 | Small Business
Elizabeth Denham

By knowing his market, working within his means, being willing to adapt to changing forces in the marketplace, and developing new products himself, Robinson, steadily formulated his plan for success.

Consuming Antibiotics

Katy Keiffer | Posted 10.05.2013 | Green
Katy Keiffer

Given the dearth of new medications in the pharmaceutical pipeline, consumers must participate in any way they can to ensure the elimination of antibiotics in livestock, save for treating specific illnesses.

Here Comes The Sunshine Act -- And It's All Right

Spencer Aronfeld | Posted 09.15.2013 | Politics
Spencer Aronfeld

The Sunshine Act will curtail the incestuous love affair enjoyed by the triumvirate of pharmaceutical companies, healthcare providers, and the insurance industry, by curbing any inappropriate influence on research, education, and clinical decision making.

In The Public Interest : Four Reasons Lawmakers Are Scrutinizing How Companies Turn Settlements From Wrongdoing Into Tax Write Offs

Phineas Baxandall | Posted 09.01.2013 | Politics
Phineas Baxandall

The oil giant BP paid for cleanup and compensation for their massive Gulf oil spill, and rightfully so. But was this a "necessary and ordinary cost of doing business" that deserved a $10 billion tax break? I think most of us would respond with a resounding, "no!"

Science, Cures and All the Stuff In Between

Margaret Anderson | Posted 08.27.2013 | Science
Margaret Anderson

The outlook for science has never been brighter -- we know more today than ever before about the molecular basis for thousands of diseases that impact millions of patients -- but the outlook for funding has also never been bleaker.

The 'Reverse Payment' Drugs Case: The Most Important Economic Issue You Never Heard of -- And Why There Might Still Be Some Hope for Antitrust

Chris Sagers | Posted 08.25.2013 | Business
Chris Sagers

Branded drug companies appear to have squeezed quite a bit more money out of their products by paying off generic drug companies to stay out of their markets. Now, you might be thinking, that sounds like a violation of antitrust law.

Child Soldiers -- The Forgotten Victims

Jonathan Agin | Posted 07.28.2013 | Impact
Jonathan Agin

This Memorial Day, we paused to offer thanks to all those men and women who have bravely and selflessly donned the uniform of our country to ensure ou...

If Frances Kelsey Could Protect America From the Pharmaceutical Industry in 1962, Congress Can Today

Peter Dreier | Posted 07.17.2013 | Politics
Peter Dreier

You've probably never of her, but Frances Kelsey may have saved your life. Sometimes it takes a scandal to get the public's attention, but it also helps to have a courageous figure who takes on big business to protect public health and safety.

Unreliable Sources 2: How the Media Help the Kochs & ExxonMobil Spread Climate Disinformation

Elliott Negin | Posted 05.14.2015 | Media
Elliott Negin

Part 2: To understand just how the fossil fuel industry has been laundering climate disinformation, there are few better places to start than with the Washington, D.C.-based Competitive Enterprise Institute.

The Wrong Way to Dispose of Drugs

Peter J. Pitts | Posted 07.08.2013 | Politics
Peter J. Pitts

Alameda County recently passed an ordinance that requires pharmaceutical companies to develop, manage and pay for a new local drug take-back program. There's good reason to believe very few people will participate in this program. It is also likely to result in higher drug prices and will produce few environmental benefits.

The Patient Choice Act - Providing Choice Instead of Death

Jonathan Agin | Posted 07.02.2013 | Impact
Jonathan Agin

As time went by during my daughter Alexis' long thirty-three month battle, we found out that her tumor was growing. We found ourselves in Manhattan seeking to gain enrollment in what looked to be a potentially promising trial. But after preliminary tests we were told that Alexis was ineligible.

Medication Nation

Mark Rubinstein | Posted 07.03.2013 | Healthy Living
Mark Rubinstein

Patients come into doctors' offices asking for something they've seen on TV. Big pharma's advertising blitz, coupled with its aggressive marketing to physicians (who all too often are readily seduced to prescribe), results in the ever-increasing number of prescriptions offered to patients.

Adequate and Well-Controlled Studies Proving Medical Efficacy of Cannabis Exist but Are Ignored by Marijuana Schedulers

Sunil Kumar Aggarwal | Posted 06.15.2013 | Politics
Sunil Kumar Aggarwal

Schedule I drugs have "no currently accepted medical use in treatment in the United States" and "a lack of accepted safety for use under medical supervision" -- a classification that holds marijuana more dangerous than cocaine, morphine, or methamphetamine.